Processa Pharmaceuticals, Inc. (PCSA) SEC Filing 8-K Material Event for the period ending Tuesday, October 2, 2018

Processa Pharmaceuticals, Inc.

CIK: 1533743 Ticker: PCSA

View differences made from one to another to evaluate Processa Pharmaceuticals, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Processa Pharmaceuticals, Inc..


Assess how Processa Pharmaceuticals, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Processa Pharmaceuticals, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Material Contracts, Statements, Certifications & more

Processa Pharmaceuticals, Inc. provided additional information to their SEC Filing as exhibits

Ticker: PCSA
CIK: 1533743
Form Type: 8-K Corporate News
Accession Number: 0001493152-18-014019
Submitted to the SEC: Tue Oct 02 2018 8:40:14 PM EST
Accepted by the SEC: Wed Oct 03 2018
Period: Tuesday, October 2, 2018
Industry: Pharmaceutical Preparations
  1. Financial Exhibit
  2. Other Events

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: